img
Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa     
Yazarlar
Nurgül Örnek
Kırıkkale Üniversitesi, Türkiye
Prof. Dr. Kemal ÖRNEK
Kırşehir Ahi Evran Üniversitesi, Türkiye
İnci Elif Erbehçeci
Özet
Macular edema (ME) in retinitis pigmentosa (RP) often impairs central vision dramatically. A 41-year-old woman diagnosed with RP was referred to our outpatient clinic due to severe visual deterioration in both eyes. The patient was treated with topical carbonic anhydrase inhibitors, topical corticosteroids and intravitreal triamcinolone acetonide injections, but her ME recurred. Intravitreal 0.7 mg dexamethasone implant (Ozurdex, Allergan) was administered into both eyes without complications. On the fourth day after both injections, visual acuity improved and ME almost totally resolved. No recurrence was observed at follow-up six months later.
Anahtar Kelimeler
Macular edema, retinitis pigmentosa, dexamethasone implant
Makale Türü Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği, araştırma notu, bilirkişi raporu ve benzeri)
Makale Alt Türü ESCI dergilerinde yayımlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden makale
Dergi Adı Turkish Journal Of Ophthalmology
Dergi ISSN 1300-0659
Dergi Tarandığı Indeksler PubMed/MEDLINE, PubMed Central (PMC), Web of Science-Emerging Sources Citation Index (ESCI), Scopus, TUBITAK/ULAKBIM, Directory of Open Access Journals (DOAJ), EBSCO Database, CINAHL, Proquest, Embase, British Library, Index Copernicus, J-Gate, ROOT INDEXING, IdealOnline, Turk Medline, EuroPub, Hinari, GOALI, ARDI, OARE, AGORA and Turkish Citation Index.
Makale Dili İngilizce
Basım Tarihi 01-2016
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
WoS 3
Google Scholar 8

Paylaş